Lower solvency than 88% of companies in human health. The sector median is 71.4%, over 563 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 2,609 companies had the same profile as SAFRANE has now. Each dot stands for 7 companies, two years later.
96.8%
were still trading
2.1%
stopped another way
1.0%
went bankrupt
Small
10 to 20 years old
solvency 10 to 30%
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,609 companies, not a prediction for SAFRANE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0507715519
Name hiddenVisible after signing in resigns as directorHidden nameVisible after signing in reappointed as director · “Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder, die nuttig of nodig zijn…” (deed in Dutch) · General meeting of 12-12-2023 · Gazette deed
Registered office moved from Oeselgem to Aarsele
The registered office moved from VAERESTRAAT 17 8720 OESELGEM to Jules Van Ooststraat 24 8700 Aarsele · Board meeting of 28-07-2022 · Gazette deed
Registered office moved from Dentergem to Oeselgem
The registered office moved from Groeneweg 25, 8720 Dentergem to Vaerestraat 17, 8720 Oeselgem · General meeting of 06-09-2016 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as SAFRANE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €650,000 and €874,000, founded between 2013 and 2015.
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of SAFRANE?
SAFRANE is a private limited company (BV).
When was SAFRANE founded?
SAFRANE was founded on 23-12-2014.
Is SAFRANE still active?
Yes, SAFRANE is an active enterprise in the KBO register.
How many employees does SAFRANE have?
SAFRANE had an average of 0.8 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of SAFRANE?
The turnover in financial year 2026 is about €770,000. This figure is estimated from the gross margin of €511,869 and 31 comparable companies (NACE 86220). It probably lies between €680,000 and €1.1m.
Is SAFRANE profitable?
In financial year 2026, SAFRANE made a profit of €369,804.
Where can I find the annual accounts of SAFRANE?
SAFRANE filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of SAFRANE due?
SAFRANE must file the annual accounts for financial year 2027 by 31-10-2027.Timeline